Cargando…
Why are there deadly drugs?
Some drugs eventually have to be removed from the market because of a negative benefit-to-harm ratio, including an excess of mortality. Drug safety is the result of multiple factors, commencing with how clinical trials are designed, the information generated by and/or hidden through these trials, tr...
Autor principal: | Lexchin, Joel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318445/ https://www.ncbi.nlm.nih.gov/pubmed/25656293 http://dx.doi.org/10.1186/s12916-015-0270-2 |
Ejemplares similares
-
Economics and industry do not mean ethical conduct in clinical trials
por: Lexchin, Joel
Publicado: (2013) -
It’s Time to Finally Kill the Zombies Comment on "Universal Pharmacare in Canada"
por: Lexchin, Joel
Publicado: (2020) -
Dead or Alive?
por: Greenbaum, Carla J.
Publicado: (2012) -
Erythropoietin for stroke treatment: dead or alive?
por: Minnerup, Jens, et al.
Publicado: (2011) -
Why the war on drugs in sport will never be won
por: Smith, Aaron C. T., et al.
Publicado: (2015)